BioCardia (BCDA) Stock Price, Quote, News & History

Comments

BioCardia Inc (BCDA) Stock Price, Quote, News & History

BCDANASDAQ

Trade with Public

$1.27

-0.01-0.78%

At close: Mar 9, 5:00 PM EST

$1.24

-0.04-3.13%

Pre-Market: 7:19 AM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$1.27

Volume / Avg.

105.00 / 80.49K

Day Range

- - -

52 Wk Range

1.00 - 3.20

Market Cap

$13.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

2.67%

Days to Cover

2.81

Recent BioCardia Inc News

Gold Falls Over 1%; Darden Posts Downbeat Earnings

Avi Kapoor

Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge

Avi Kapoor

Why BioCardia (BCDA) Stock Is Falling Today

BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.51M

Investing Cash Flow (TTM)

-2.00K

Financing Cash Flow (TTM)

7.87M

Free Cash Flow (TTM)

-7.51M

Capital Expenditure (TTM)

-2.00K

Net Change in Cash (TTM)

357.00K

Analyst Trends and Forecast

1

Sep 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.83M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.13

Earnings Yield % (TTM)

-111.81%

Earnings Yield % (FWD)

-64.57%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.25

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.29M

Debt to Equity

0.24

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$1.27

Volume / Avg.

105.00 / 80.49K

Day Range

- - -

52 Wk Range

1.00 - 3.20

Market Cap

$13.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

2.67%

Days to Cover

2.81

About

Sector

Health Care

Industry

Biotechnology

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy BioCardia (BCDA) stock?

A

You can purchase shares of BioCardia (NASDAQ:BCDA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioCardia (BCDA) competitors?

A

Other companies in BioCardia’s space includes: Serina Therapeutics Inc (AMEX:SER), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX), Curis Inc (NASDAQ:CRIS), Cellectar Biosciences Inc (NASDAQ:CLRB) and Imunon Inc (NASDAQ:IMNN).

Q

What is the forecast, or price target, for BioCardia (BCDA) stock?

A

BioCardia has a consensus price target of $25.00.

Q

What is the current price for BioCardia (BCDA)?

A

The stock price for BioCardia (NASDAQ: BCDA) is $1.24 last updated March 10, 2026 at 7:36 PM EDT.

Q

Does BioCardia (BCDA) pay a dividend?

A

There are no upcoming dividends for BioCardia.

Q

When is BioCardia (NASDAQ:BCDA) reporting earnings?

A

BioCardia does not have any upcoming earnings scheduled.

Q

Is BioCardia (BCDA) going to split?

A

There is no upcoming split for BioCardia.

Q

What sector and industry does BioCardia (BCDA) operate in?

A

BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

SER

Quoin Pharmaceuticals Ltd

Cellectar Biosciences Inc

Intensity Therapeutics Inc

APUS

Key Statistics

Open

-

Close

$1.27

Volume / Avg.

105.00 / 80.49K

Day Range

- - -

52 Wk Range

1.00 - 3.20

Market Cap

$13.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

2.67%

Days to Cover

2.81

Recent BioCardia Inc News

Gold Falls Over 1%; Darden Posts Downbeat Earnings

Avi Kapoor

Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge

Avi Kapoor

Why BioCardia (BCDA) Stock Is Falling Today

BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.51M

Investing Cash Flow (TTM)

-2.00K

Financing Cash Flow (TTM)

7.87M

Free Cash Flow (TTM)

-7.51M

Capital Expenditure (TTM)

-2.00K

Net Change in Cash (TTM)

357.00K

Analyst Trends and Forecast

1

Sep 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.83M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.13

Earnings Yield % (TTM)

-111.81%

Earnings Yield % (FWD)

-64.57%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.25

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.29M

Debt to Equity

0.24

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$1.27

Volume / Avg.

105.00 / 80.49K

Day Range

- - -

52 Wk Range

1.00 - 3.20

Market Cap

$13.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

2.67%

Days to Cover

2.81

About

Sector

Health Care

Industry

Biotechnology

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry